ScholarIQanswers from OpenAlex
Anti-Cancer Drugs
JournalCitation impact & published research
Anti-Cancer Drugs is a journal indexed in ScholarIQ from OpenAlex.
What is the OpenAlex record for Anti-Cancer Drugs?
ScholarIQopenalex
The OpenAlex for Anti-Cancer Drugs is on the source record.
What are the most-cited papers on Anti-Cancer Drugs?
ScholarIQmost cited works
Yondelis® (trabectedin, ET-743): the development of an anticancer agent of marine origin
Ch. van Kesteren, M. M. M. de Vooght, Luis López Lázaro, Ron A. A. Mathôt, Jan H.M. Schellens, José Jimeno, Jos H. Beijnen
Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression
Qun Hang, Ruochuan Sun, Congqiao Jiang, Yongxiang Li
PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
Xiaofang Xing, Lianhai Zhang, Xianzi Wen, Xiaohong Wang, Xiaojing Cheng, Hong Du, Ying Hu, Lin Li, Bin Dong, Ziyu Li, Jiafu Ji
Potential cost savings owing to the route of administration of oncology drugs
M Franken, Tim A. Kanters, Jules L.L.M. Coenen, Paul de Jong, Harry R. Koene, Pieternella J. Lugtenburg, Agnes Jager, Carin A. Uyl‐de Groot
Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study
Takashi Kurosaki, Seiichiro Mitani, Kaoru Tanaka, Shinichiro Suzuki, Hiroaki Kanemura, Koji Haratani, Soichi Fumita, Tsutomu Iwasa, Hidetoshi Hayashi, Takeshi Yoshida, Kazuki Ishikawa, Mutsukazu Kitano, Naoki Otsuki, Yasumasa Nishimura, Katsumi Doi, Kazuhiko Nakagawa